Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 241-993-2 | CAS number: 18088-11-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
A guideline and GLP compliant bacterial reverse mutation study is available for the submission substance
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- Experimental start date: 29 November 2017. Experimental completion date: 15 December 2017.
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Version / remarks:
- 1997 version
- Deviations:
- no
- GLP compliance:
- yes
- Remarks:
- No analysis was carried out to determine the homogeneity, concentration or stability of the test item formulation. The test item was formulated within four hours of it being applied to the test system and therefore study integrity is not compromised
- Type of assay:
- bacterial reverse mutation assay
- Specific details on test material used for the study:
- The test substance was Rubidium Oxide 45.8 wt% in water. Dirubidium oxide is hygroscopic, highly basic and reacts strongly with water to produce rubidium hydroxide. As dirubidium oxide is chemically unstable and not used in its isolated form, testing has been performed on an aqueous solution of rubidium hydroxide because test material was applied as aqueous solutions.
SOURCE OF TEST MATERIAL
- Source and lot/batch No.of test material: S19D031
- Expiration date of the lot/batch: 20 October 2018
STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: Room temperature in the dark - Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Species / strain / cell type:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9 Microsomal fractions (CD Sprague-Dawley)
- Test concentrations with justification for top dose:
- Experiment 1 (Plate Incorporation Method): 1.5, 5, 15, 50, 150, 500, 1500, 5000 µg/plate.
Experiment 2 (Pre-Incubation Method): 5, 15, 50, 150, 500, 1500, 5000 µg/plate. - Vehicle / solvent:
- Sterile distilled water.
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- Positive controls:
- yes
- Positive control substance:
- 4-nitroquinoline-N-oxide
- 9-aminoacridine
- N-ethyl-N-nitro-N-nitrosoguanidine
- benzo(a)pyrene
- other: 2-Aminoanthracene
- Details on test system and experimental conditions:
- All of the Salmonella strains are histidine dependent by virtue of a mutation through the histidine operon and are derived from S. typhimurium strain LT2 through mutations in the histidine locus. Additionally due to the "deep rough" (rfa-) mutation they possess a faulty lipopolysaccharide coat to the bacterial cell surface thus increasing the cell permeability to larger molecules. A further mutation, through the deletion of the uvrB- bio gene, causes an inactivation of the excision repair system and a dependence on exogenous biotin. In the strains TA98 and TA100, the R-factor plasmid pKM101 enhances chemical and UV-induced mutagenesis via an increase in the error-prone repair pathway. The plasmid also confers ampicillin resistance which acts as a convenient marker (Mortelmans and Zeiger, 2000). In addition to a mutation in the tryptophan operon, the E. coli tester strain contains a uvrA- DNA repair deficiency which enhances its sensitivity to some mutagenic compounds. This deficiency allows the strain to show enhanced mutability as the uvrA repair system would normally act to remove and repair the damaged section of the DNA molecule (Green and Muriel, 1976 and Mortelmans and Riccio, 2000).
In this assay, overnight sub-cultures of the appropriate coded stock cultures were prepared in nutrient broth (Oxoid Limited; lot number 1865318 05/21) and incubated at 37 °C for approximately 10 hours. Each culture was monitored spectrophotometrically for turbidity with titres determined by viable count analysis on nutrient agar plates.
The S9 Microsomal fractions (CD Sprague-Dawley) were pre-prepared using standardized in-house procedures (outside the confines of this study). Lot Number PB/βNF S9 01 October 2017 was used in this study.
The S9-mix was prepared before use using sterilized co-factors and maintained on ice for the duration of the test: S9 5.0 mL, 1.65 M KCl/0.4 M MgCl2 1.0 mL, 0.1 M Glucose-6-phosphate 2.5 mL, 0.1 M NADP 2.0 mL, 0.2 M Sodium phosphate buffer (pH 7.4) 25.0 mL, Sterile distilled water 14.5 mL.
A 0.5 mL aliquot of S9-mix and 2 mL of molten, trace histidine or tryptophan supplemented, top agar were overlaid onto a sterile Vogel-Bonner Minimal agar plate in order to assess the sterility of the S9-mix. This procedure was repeated, in triplicate, on the day of each experiment.
Top agar was prepared using 0.6% Bacto agar (lot number 6221620 06/21) and 0.5% sodium chloride with 5 mL of 1.0 mM histidine and 1.0 mM biotin or 1.0 mM tryptophan solution added to each 100 mL of top agar. Vogel-Bonner Minimal agar plates were purchased from SGL Ltd (lot numbers 45930 12/2017 and 46055 01/2018).
Prior to use, the master strains were checked for characteristics, viability and spontaneous reversion rate (all were found to be satisfactory). The amino acid supplemented top agar and the S9-mix used in both experiments was shown to be sterile. The test item formulation was also shown to be sterile. These data are not given in the report. - Rationale for test conditions:
- As specified in the guidelines
- Evaluation criteria:
- There are several criteria for determining a positive result. Any, one, or all of the following can be used to determine the overall result of the study:
1. A dose-related increase in mutant frequency over the dose range tested (De Serres and Shelby, 1979).
2. A reproducible increase at one or more concentrations.
3. Biological relevance against in-house historical control ranges.
4. Statistical analysis of data as determined by UKEMS (Mahon et al., 1989).
5. Fold increase greater than two times the concurrent solvent control for any tester strain (especially if accompanied by an out-of-historical range response (Cariello and Piegorsch, 1996)).
A test item will be considered non-mutagenic (negative) in the test system if the above criteria are not met.
Although most experiments will give clear positive or negative results, in some instances the data generated will prohibit making a definite judgment about test item activity. Results of this type will be reported as equivocal. - Statistics:
- Statistical significance was confirmed by using Dunnetts Regression Analysis (* = p < 0.05) for those values that indicate statistically significant increases in the frequency of revertant colonies compared to the concurrent solvent control. Values that the program concluded as statistically significant but were within the in-house historical profile were not reported.
- Key result
- Species / strain:
- S. typhimurium TA 100
- Remarks:
- Plate incorporation
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- 5000 µg/plate in the absence of S9
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 1535
- Remarks:
- Plate incorporation
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- E. coli WP2 uvr A
- Remarks:
- Plate incorporation
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 98
- Remarks:
- Plate incorporation
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 100
- Remarks:
- Pre-incubation
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 1535
- Remarks:
- Pre-incubation
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- E. coli WP2 uvr A
- Remarks:
- Pre-incubation
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 98
- Remarks:
- Pre-incubation
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 1537
- Remarks:
- Pre-incubation
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- Results for the negative controls (spontaneous mutation rates) are presented in Table 1 and were considered to be acceptable. These data are for concurrent untreated control plates performed on the same day as the Mutation Test.
The vehicle (sterile distilled water) control plates gave counts of revertant colonies within the normal range. All of the positive control chemicals used in the test induced marked increases in the frequency of revertant colonies, both with or without metabolic activation. Thus, the sensitivity of the assay and the efficacy of the S9-mix were validated.
The mean number of revertant colonies, for the test item, positive and vehicle controls, both with and without metabolic activation, are presented in Table 2 for Experiment 1 (plate incorporation method) and Experiment 2 (pre-incubation method).
In the first experiment (plate incorporation method), the maximum dose level of the test item was 5000 μg/plate (the maximum concentration). Weakened bacterial background lawns were noted in one strain only (TA100 dosed in the absence of S9-mix) at 5000 μg/plate. There was no visible reduction in the growth of the bacterial background lawns noted to any of the remaining tester strains in either the absence or presence of S9-mix at any test item dose level.
These results from Experiment 1 were not indicative of toxicity sufficiently severe enough to prevent the test item being tested up to the maximum recommended dose level of 5000 μg/plate. In the second experiment (pre-incubation method), the test item induced a slightly stronger toxic response with weakened bacterial background lawns noted at 5000 μg/plate to TA100 and TA1535 in the absence of S9-mix and to all of the tester strains at the same concentration in the presence of S9-mix. There was no visible reduction in the growth of the bacterial background lawns noted to any of the remaining tester strains (WP2uvrA, TA98 and TA1537 dosed in the absence of S9-mix).
No test item precipitate was observed on the plates at any of the doses tested in either the presence or absence of S9-mix.
There were no increases in the frequency of revertant colonies recorded for any of the bacterial strains, with any dose of the test item, either with or without metabolic activation (S9-mix) in Experiment 1 (plate incorporation method). Similarly, no toxicologically meaningful increases in the frequency of revertant colonies were recorded for any of the bacterial strains, with any dose of the test item, either with or without metabolic activation (S9-mix) in Experiment 2 (pre-incubation method). A small, statistically significant increase in TA1537 revertant colony frequency was observed in the presence of S9-mix at 5 μg/plate in the second mutation test. However, this response was within the in-house historical vehicle/untreated control values for the bacterial strain and was, therefore, considered of no biological relevance. - Conclusions:
- Rubidium Oxide was considered to be non-mutagenic under the conditions of this test.
- Executive summary:
The Ames test was conducted according to OECD (1997 version) guideline 471 and GLP (1997 version). Salmonella typhimurium strains TA1535, TA1537, TA98 and TA100 and Escherichia coli strain WP2uvrA were treated with the test item using both the Ames plate incorporation and pre-incubation methods at up to eight dose levels, in triplicate, both with and without the addition of a rat liver homogenate metabolizing system (10% liver S9 in standard co-factors). The dose range for Experiment 1 was predetermined and was 1.5 to 5000 μg/plate. The experiment was repeated on a separate day (pre-incubation method) using fresh cultures of the bacterial strains and fresh test item formulations. The dose range was amended following the results of Experiment 1 and was 5 to 5000 μg/plate. Seven test item concentrations per bacterial strain were selected in Experiment 2 in order to achieve both four non-toxic dose levels and the toxic limit of the test item following the change in test methodology.
The vehicle (sterile distilled water) control plates gave counts of revertant colonies within the normal range. All of the positive control chemicals used in the test induced marked increases in the frequency of revertant colonies, both with or without metabolic activation. Thus, the sensitivity of the assay and the efficacy of the S9-mix were validated.
In the first experiment (plate incorporation method), the maximum dose level of the test item was 5000 μg/plate (the maximum concentration). Weakened bacterial background lawns were noted in one strain only (TA100 dosed in the absence of S9-mix) at 5000 μg/plate. There was no visible reduction in the growth of the bacterial background lawns noted to any of the remaining tester strains in either the absence or presence of S9-mix at any test item dose level.
These results from Experiment 1 were not indicative of toxicity sufficiently severe enough to prevent the test item being tested up to the maximum recommended dose level of 5000 μg/plate. In the second experiment (pre-incubation method), the test item induced a slightly stronger toxic response with weakened bacterial background lawns noted at 5000 μg/plate to TA100 and TA1535 in the absence of S9-mix and to all of the tester strains at the same concentration in the presence of S9-mix. There was no visible reduction in the growth of the bacterial background lawns noted to any of the remaining tester strains (WP2uvrA, TA98 and TA1537 dosed in the absence of S9-mix).
No test item precipitate was observed on the plates at any of the doses tested in either the presence or absence of S9-mix.
There were no increases in the frequency of revertant colonies recorded for any of the bacterial strains, with any dose of the test item, either with or without metabolic activation (S9-mix) in Experiment 1 (plate incorporation method). Similarly, no toxicologically meaningful increases in the frequency of revertant colonies were recorded for any of the bacterial strains, with any dose of the test item, either with or without metabolic activation (S9-mix) in Experiment 2 (pre-incubation method). A small, statistically significant increase in TA1537 revertant colony frequency was observed in the presence of S9-mix at 5 μg/plate in the second mutation test. However, this response was within the in-house historical vehicle/untreated control values for the bacterial strain and was, therefore, considered of no biological relevance.
Reference
Table 1.Spontaneous Mutation Rates (Concurrent Negative Controls)
EXPERIMENT 1 (PLATE INCORPORATION) |
||||
TA100 |
TA1535 |
WP2uvrA |
TA98 |
TA1537 |
106 |
15 |
28 |
21 |
8 |
111 |
14 |
18 |
24 |
5 |
102 |
15 |
26 |
25 |
8 |
EXPERIMENT 2 (PREINCUBATION) |
||||
TA100 |
TA1535 |
WP2uvrA |
TA98 |
TA1537 |
127 |
21 |
25 |
23 |
13 |
128 |
19 |
10 |
25 |
8 |
128 |
11 |
15 |
23 |
7 |
Table 2. Test Results
Mean revertant numbers |
||||||||||
Treatment |
EXPERIMENT 1 (PLATE INCORPORATION) |
|||||||||
TA100 |
TA1535 |
WP2uvrA |
TA98 |
TA1537 |
||||||
-S9 |
+S9 |
-S9 |
+S9 |
-S9 |
+S9 |
-S9 |
+S9 |
-S9 |
+S9 |
|
Solvent |
114 |
107 |
15 |
12 |
31 |
26 |
21 |
31 |
10 |
13 |
1.5 µg |
114 |
90 |
11 |
16 |
35 |
22 |
22 |
24 |
13 |
10 |
5 µg |
111 |
103 |
12 |
10 |
28 |
25 |
16 |
23 |
8 |
8 |
15 µg |
106 |
104 |
15 |
14 |
30 |
21 |
20 |
23 |
8 |
11 |
50 µg |
110 |
102 |
13 |
12 |
25 |
22 |
18 |
19 |
13 |
12 |
150 µg |
107 |
92 |
13 |
11 |
29 |
24 |
19 |
25 |
7 |
5 |
500 µg |
107 |
97 |
14 |
12 |
31 |
19 |
18 |
29 |
10 |
6 |
1500 µg |
103 |
98 |
14 |
11 |
31 |
21 |
20 |
29 |
12 |
9 |
5000 µg |
83 |
80 |
12 |
12 |
26 |
25 |
18 |
24 |
10 |
10 |
ENNG |
523 |
- |
276 |
- |
931 |
- |
- |
- |
- |
- |
4NQO |
- |
- |
- |
- |
- |
- |
201 |
- |
- |
- |
9AA |
- |
- |
- |
- |
- |
- |
- |
- |
384 |
- |
2AA |
- |
1574 |
- |
302 |
- |
216 |
- |
- |
- |
402 |
BP |
- |
- |
- |
- |
- |
- |
- |
226 |
- |
- |
Treatment |
EXPERIMENT 2 (PREINCUBATION) |
|||||||||
TA100 |
TA1535 |
WP2uvrA |
TA98 |
TA1537 |
||||||
-S9 |
+S9 |
-S9 |
+S9 |
-S9 |
+S9 |
-S9 |
+S9 |
-S9 |
+S9 |
|
Solvent |
102 |
107 |
14 |
11 |
25 |
29 |
18 |
25 |
8 |
10 |
5 µg |
107 |
96 |
13 |
10 |
21 |
33 |
23 |
26 |
9 |
20 |
15 µg |
106 |
89 |
19 |
12 |
22 |
28 |
27 |
21 |
15 |
17 |
50 µg |
110 |
94 |
18 |
9 |
24 |
32 |
24 |
25 |
12 |
15 |
150 µg |
114 |
91 |
17 |
15 |
25 |
25 |
22 |
31 |
13 |
16 |
500 µg |
97 |
97 |
14 |
12 |
22 |
24 |
27 |
29 |
16 |
11 |
1500 µg |
104 |
104 |
13 |
12 |
25 |
29 |
23 |
22 |
14 |
7 |
5000 µg |
104 |
42 |
12 |
4 |
23 |
31 |
18 |
17 |
10 |
6 |
ENNG |
879 |
- |
688 |
- |
800 |
- |
- |
- |
- |
- |
4NQO |
- |
- |
- |
- |
- |
- |
147 |
- |
- |
- |
9AA |
- |
- |
- |
- |
- |
- |
- |
- |
132 |
- |
2AA |
- |
1223 |
- |
244 |
- |
172 |
- |
- |
- |
258 |
BP |
- |
- |
- |
- |
- |
- |
- |
117 |
- |
- |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Additional information
Bacterial reverse mutation assay
The Ames test was conducted according to OECD (1997 version) guideline 471 and GLP (1997 version). Salmonella typhimurium strains TA1535, TA1537, TA98 and TA100 and Escherichia coli strain WP2uvrA were treated with the test item using both the Ames plate incorporation and pre-incubation methods at up to eight dose levels, in triplicate, both with and without the addition of a rat liver homogenate metabolizing system (10% liver S9 in standard co-factors). The dose range for Experiment 1 was predetermined and was 1.5 to 5000 μg/plate. The experiment was repeated on a separate day (pre-incubation method) using fresh cultures of the bacterial strains and fresh test item formulations. The dose range was amended following the results of Experiment 1 and was 5 to 5000 μg/plate. Seven test item concentrations per bacterial strain were selected in Experiment 2 in order to achieve both four non-toxic dose levels and the toxic limit of the test item following the change in test methodology.
The vehicle (sterile distilled water) control plates gave counts of revertant colonies within the normal range. All of the positive control chemicals used in the test induced marked increases in the frequency of revertant colonies, both with or without metabolic activation. Thus, the sensitivity of the assay and the efficacy of the S9-mix were validated.
In the first experiment (plate incorporation method), the maximum dose level of the test item was 5000 μg/plate (the maximum concentration). Weakened bacterial background lawns were noted in one strain only (TA100 dosed in the absence of S9-mix) at 5000 μg/plate. There was no visible reduction in the growth of the bacterial background lawns noted to any of the remaining tester strains in either the absence or presence of S9-mix at any test item dose level.
These results from Experiment 1 were not indicative of toxicity sufficiently severe enough to prevent the test item being tested up to the maximum recommended dose level of 5000 μg/plate. In the second experiment (pre-incubation method), the test item induced a slightly stronger toxic response with weakened bacterial background lawns noted at 5000 μg/plate to TA100 and TA1535 in the absence of S9-mix and to all of the tester strains at the same concentration in the presence of S9-mix. There was no visible reduction in the growth of the bacterial background lawns noted to any of the remaining tester strains (WP2uvrA, TA98 and TA1537 dosed in the absence of S9-mix).
No test item precipitate was observed on the plates at any of the doses tested in either the presence or absence of S9-mix.
There were no increases in the frequency of revertant colonies recorded for any of the bacterial strains, with any dose of the test item, either with or without metabolic activation (S9-mix) in Experiment 1 (plate incorporation method). Similarly, no toxicologically meaningful increases in the frequency of revertant colonies were recorded for any of the bacterial strains, with any dose of the test item, either with or without metabolic activation (S9-mix) in Experiment 2 (pre-incubation method). A small, statistically significant increase in TA1537 revertant colony frequency was observed in the presence of S9-mix at 5 μg/plate in the second mutation test. However, this response was within the in-house historical vehicle/untreated control values for the bacterial strain and was, therefore, considered of no biological relevance.
Justification for classification or non-classification
A negative result was observed for the submission substance in the bacterial reverse mutation assay (Ames test).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.